Top compounds associated with response to SPRYD3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA manumycin A CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA MST-312 CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA Vorinostat gCSI pan-cancer AAC -0.22 6e-05
mRNA pifithrin-mu CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA decitabine CTRPv2 pan-cancer AAC -0.11 8e-05
mRNA pac-1 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0001
Download CSV